3.14. Analysis.

Comparison 3 Rivastigmine 20 cm2 patch (17.4 mg/day) versus placebo, Outcome 14 at least one adverse event of decreased appetite by 24 weeks.

Comparison 3 Rivastigmine 20 cm2 patch (17.4 mg/day) versus placebo, Outcome 14 at least one adverse event of decreased appetite by 24 weeks.